Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals


Ozaras R., Mete B., Tabak F.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol.15, no.4, pp.605, 2017 (SCI-Expanded) identifier identifier identifier